Works matching AU Herwandhani Putri
Results: 15
Targets and molecular mechanisms of a citrus flavonoid, hesperidin, against luminal breast cancer cells: an integrative bioinformatics analysis.
- Published in:
- Asian Pacific Journal of Tropical Biomedicine, 2019, v. 9, n. 12, p. 531, doi. 10.4103/2221-1691.271727
- By:
- Publication type:
- Article
Bioinformatics Analysis of Programmed Death-1–Trastuzumab Resistance Regulatory Networks in Breast Cancer Cells.
- Published in:
- Asian Pacific Journal of Cancer Prevention, 2025, v. 26, n. 1, p. 279, doi. 10.31557/APJCP.2025.26.1.279
- By:
- Publication type:
- Article
In Vitro Study of the Combination of Doxorubicin, Curcuma xanthorrhiza, Brucea javanica, and Ficus séptica as a Potential Novel Therapy for Metastatic Breast Cancer.
- Published in:
- Indonesian Journal of Pharmacy / Majalah Farmasi Indonesia, 2019, v. 30, n. 1, p. 15, doi. 10.14499/indonesianjpharm30iss1pp15
- By:
- Publication type:
- Article
SYNTHESIS AND CYTOTOXIC ACTIVITY OF 2,5-BIS(4-BORONIC ACID)BENZYLIDINE CYCLOPENTANONE ON HER2 OVEREXPRESSED-CANCER CELLS.
- Published in:
- Indonesian Journal of Pharmacy / Majalah Farmasi Indonesia, 2017, v. 28, n. 2, p. 74, doi. 10.14499/indonesianjpharm28iss2pp74
- By:
- Publication type:
- Article
Bioinformatics and In Vitro Studies Reveal the Importance of p53, PPARG and Notch Signaling Pathway in Inhibition of Breast Cancer Stem Cells by Hesperetin.
- Published in:
- Advanced Pharmaceutical Bulletin, 2021, v. 11, n. 2, p. 351, doi. 10.34172/apb.2021.033
- By:
- Publication type:
- Article
The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells.
- Published in:
- Advanced Pharmaceutical Bulletin, 2021, v. 11, n. 1, p. 188
- By:
- Publication type:
- Article
Anti-proliferative and Anti-metastatic Potential of Curcumin Analogue, Pentagamavunon-1 (PGV-1), Toward Highly Metastatic Breast Cancer Cells in Correlation with ROS Generation.
- Published in:
- Advanced Pharmaceutical Bulletin, 2019, v. 9, n. 3, p. 445, doi. 10.15171/apb.2019.053
- By:
- Publication type:
- Article
Functional network analysis reveals potential repurposing of β-blocker atenolol for pancreatic cancer therapy.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2020, v. 28, p. 685, doi. 10.1007/s40199-020-00375-4
- By:
- Publication type:
- Article
Cardioprotective and hepatoprotective effects of Citrus hystrix peels extract on rats model
- Published in:
- Asian Pacific Journal of Tropical Biomedicine, 2013, v. 3, n. 5, p. 371, doi. 10.1016/S2221-1691(13)60079-9
- By:
- Publication type:
- Article
Computational analysis of G-protein-coupled receptor kinase family members as potential targets for colorectal cancer therapy.
- Published in:
- Egyptian Journal of Medical Human Genetics, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s43042-022-00349-y
- By:
- Publication type:
- Article
Comprehensive bioinformatics study reveals targets and molecular mechanism of hesperetin in overcoming breast cancer chemoresistance.
- Published in:
- Molecular Diversity, 2020, v. 24, n. 4, p. 933, doi. 10.1007/s11030-019-10003-2
- By:
- Publication type:
- Article
Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy.
- Published in:
- BMC Genomic Data, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12863-022-01086-2
- By:
- Publication type:
- Article
Characterizing excision repair cross-complementing family genes as drug resistance biomarkers in breast cancer.
- Published in:
- Beni-Suef University Journal of Basic & Applied Sciences, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s43088-023-00415-3
- By:
- Publication type:
- Article
Bioinformatics Analysis of TIMP1, HK2 and IGFBP7 as Potential Biomarkers and Therapeutic Targets of Paclitaxel Resistance in Breast Cancer.
- Published in:
- Middle East Journal of Cancer, 2021, v. 12, n. 2, p. 198, doi. 10.30476/mejc.2020.83374.1159
- By:
- Publication type:
- Article
Bioinformatics Analysis of the Genetic and Epigenetic Alterations of Bone Morphogenetic Protein Receptors in Metastatic Breast Cancer.
- Published in:
- Biochemical Genetics, 2024, v. 62, n. 2, p. 594, doi. 10.1007/s10528-023-10445-2
- By:
- Publication type:
- Article